Optimizing Combination Radiation Therapy And Immunotherapy

Optimizing Combination Radiation Therapy And Immunotherapy

Due Date: 11/17/2025

The Radiation Oncology Institute (ASTRO Foundation) seeks high-impact research to optimize how radiation therapy and immunotherapy are combined to improve patient outcomes and advance access to care.

Eligibility Criteria:

  • Qualified individuals in the radiation oncology community; pre-doctoral students are not eligible.

  • Residents/fellows require a faculty mentor.

  • Grant funds must be managed by a U.S. 501(c)(3) or government-sponsored university (or Canadian equivalent).

  • One LOI per applicant.

Funding Details:

  • Typical total budget up to USD 50,000 over 2 years; maximum USD 100,000.

  • No indirect/overhead costs allowed.

  • Project term: up to 2 years (anticipated start August 1, 2026; end no later than July 31, 2028).

  • PI salary/benefits capped at the lesser of 20% of the award or USD 10,000 total.

Deadline:

  • Letter Of Intent: November 17, 2025

  • Full Proposal Invitations: December 2025

  • Full Proposal (By Invitation): February 17, 2026

  • Notification Of Awards: April 2026

  • Award Start Date: August 1, 2026

Where To Go For Further Information: